{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:01:05Z","timestamp":1777507265236,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.addr.2007.05.016","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T11:08:24Z","timestamp":1187348904000},"page":"79-87","source":"Crossref","is-referenced-by-count":50,"title":["PEGylation of cyanovirin\u2013N, an entry inhibitor of HIV"],"prefix":"10.1016","volume":"60","author":[{"given":"H.","family":"Zappe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2007.05.016_bib1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.1112489","article-title":"HIV\/AIDS in women: an expanding epidemic","volume":"308","author":"Quinn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.addr.2007.05.016_bib2","first-page":"48","article-title":"Parenteral inhibitors of HIV entry in current development","volume":"2","author":"Lalezari","year":"2006","journal-title":"J. Viral Entry"},{"key":"10.1016\/j.addr.2007.05.016_bib3","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.vaccine.2006.02.031","article-title":"A review of vaccine research and development: the human immunodeficiency virus (HIV)","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2007.05.016_bib4","series-title":"FDA approves first drug in new class of HIV treatments for HIV infected adults and children with advanced disease","year":"2003"},{"key":"10.1016\/j.addr.2007.05.016_bib5","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1128\/JVI.78.19.10617-10627.2004","article-title":"Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins","volume":"78","author":"Balzarini","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.05.016_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/dkl027","article-title":"HIV entry inhibitors: mechanisms of action and resistance pathways","volume":"57","author":"Briz","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2007.05.016_bib7","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.41.7.1521","article-title":"Discovery of cyanovirin\u2013N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development","volume":"41","author":"Boyd","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.05.016_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00042560-199603010-00001","article-title":"Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. HIV\/AIDS in women: an expanding epidemic","volume":"11","author":"Pauwels","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Human Retrovirol."},{"key":"10.1016\/j.addr.2007.05.016_bib9","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1128\/JVI.74.10.4562-4569.2000","article-title":"Multiple antiviral activities of cyanovirin\u2013N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses","volume":"74","author":"Dey","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.05.016_bib10","doi-asserted-by":"crossref","first-page":"25177","DOI":"10.1074\/jbc.M602431200","article-title":"Cyanovirin\u2013N inhibits hepatitis C virus entry by binding to envelope protein glycans","volume":"281","author":"Helle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.05.016_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.47.8.2518-2525.2003","article-title":"Potent anti-influenza activity of cyanovirin\u2013N and interactions with viral hemagglutinin","volume":"47","author":"O'Keefe","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.05.016_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(02)00183-3","article-title":"Cyanovirin\u2013N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus","volume":"58","author":"Barrientos","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2007.05.016_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/protein\/gzl040","article-title":"Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition","volume":"19","author":"Barrientos","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.addr.2007.05.016_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/bbrc.1997.7203","article-title":"Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum","volume":"238","author":"Gustafson","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2007.05.016_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/828","article-title":"Solution structure of cyanovirin\u2013N, a potent HIV-inactivating protein","volume":"5","author":"Bewley","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.addr.2007.05.016_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/jmbi.1999.2693","article-title":"Crystal structure of cyanovirin\u2013N, a potent HIV-inactivating protein, shows unexpected domain swapping","volume":"288","author":"Yang","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2007.05.016_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.antiviral.2006.02.004","article-title":"Inhibition of HIV entry by carbohydrate-binding proteins","volume":"71","author":"Balzarini","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2007.05.016_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pbiomolbio.2004.05.001","article-title":"Proteins that bind high-mannose sugars of the HIV envelope","volume":"88","author":"Botos","year":"2005","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.addr.2007.05.016_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.addr.2007.05.016_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2007.05.016_bib21","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/ja004040e","article-title":"The potent anti-HIV protein cyanovirin\u2013N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120","volume":"123","author":"Bewley","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2007.05.016_bib22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/mol.59.5.949","article-title":"Cyanovirin\u2013N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner","volume":"59","author":"Bolmstedt","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2007.05.016_bib23","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1016\/S0021-9258(18)37849-9","article-title":"Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120","volume":"263","author":"Geyer","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.05.016_bib24","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells","volume":"265","author":"Leonard","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.05.016_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/AAC.45.3.664-672.2001","article-title":"Cyanovirin\u2013N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells","volume":"45","author":"Mori","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.05.016_bib26","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00002030-200207050-00006","article-title":"The microbicide cyanovirin\u2013N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1","volume":"16","author":"Giomarelli","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2007.05.016_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/prep.1997.0838","article-title":"Recombinant production of cyanovirin\u2013N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium","volume":"12","author":"Mori","year":"1998","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.addr.2007.05.016_bib28","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/AAC.00493-06","article-title":"Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin\u2013N","volume":"50","author":"Liu","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.05.016_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.qai.0000187446.76579.d3","article-title":"Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin","volume":"40","author":"Pusch","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr. (1999)"},{"key":"10.1016\/j.addr.2007.05.016_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1096\/fj.05-4742fje","article-title":"Transgenic plant production of Cyanovirin\u2013N, an HIV microbicide","volume":"20","author":"Sexton","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2007.05.016_bib31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1006\/bbrc.1997.7505","article-title":"Construction and enhanced cytotoxicity of a [cyanovirin\u2013N]-[Pseudomonas exotoxin] conjugate against human immunodeficiency virus-infected cells","volume":"239","author":"Mori","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2007.05.016_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2007.05.016_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","article-title":"Peptide and protein PEGylation: a review of problems and solutions","volume":"22","author":"Veronese","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2007.05.016_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-409X(93)90005-O","article-title":"The conjugation of proteins with polyethylene glycol and other polymers. Altering properties of proteins to enhance their therapeutic potential","volume":"10","author":"Katre","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2007.05.016_bib35","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/ja004040e","article-title":"The potent anti-HIV protein cyanovirin\u2013N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120","volume":"123","author":"Bewley","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2007.05.016_bib36","series-title":"Molecular Cloning. A laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.addr.2007.05.016_bib37","volume":"vol. 1","year":"1988"},{"key":"10.1016\/j.addr.2007.05.016_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0076-6879(89)78034-4","article-title":"Production and properties of chimeric antibody molecules","volume":"178","author":"Shin","year":"1989","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2007.05.016_bib39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0969-2126(02)00758-X","article-title":"The domain-swapped dimer of cyanovirin\u2013N is in a metastable folded state: reconciliation of X-ray and NMR structures","volume":"10","author":"Barrientos","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.addr.2007.05.016_bib40","first-page":"4","article-title":"The molecular basis of HIV entry and its inhibition","volume":"2","author":"Laakso","year":"2006","journal-title":"J. Viral Entry"},{"key":"10.1016\/j.addr.2007.05.016_bib41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2165\/00003495-200565130-00002","article-title":"Emerging drug targets for antiretroviral therapy","volume":"65","author":"Reeves","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2007.05.016_bib42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/13543784.11.8.1077","article-title":"Considerations and development of topical microbicides to inhibit the sexual transmission of HIV","volume":"11","author":"Turpin","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2007.05.016_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)65591-5","article-title":"Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission","volume":"153","author":"Patterson","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2007.05.016_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00003081-199303000-00017","article-title":"Immunology of the vagina","volume":"36","author":"Witkin","year":"1993","journal-title":"Clin. Obstet. Gynecol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T23:40:14Z","timestamp":1629589214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X07001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0169409X07001408"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2007.05.016","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}